Martin Gill
MG
Martin Gill
Chief Scientific Officer at Libra Therapeutics
Rate
About
Martin Gill is the Chief Scientific Officer at Libra Therapeutics, a biotechnology company focused on developing novel disease-modifying therapeutics for neurodegenerative diseases. He previously served as Senior Vice President and Head of Research at Libra Therapeutics. Prior to joining Libra, he was Head of In Vitro Discovery at Neuropore Therapies and also held positions at Bristol Myers Squibb.
Frequently asked
Who is Martin Gill?
Martin Gill is the Chief Scientific Officer at Libra Therapeutics, a biotechnology company focused on developing novel disease-modifying therapeutics for neurodegenerative diseases. He previously served as Senior Vice President and Head of Research at Libra Therapeutics. Prior to joining Libra, he was Head of In Vitro Discovery at Neuropore Therapies and also held positions at Bristol Myers Squibb…
What is Martin Gill's current role?
Martin Gill is currently Chief Scientific Officer at Libra Therapeutics.
Comments
No comments yet. Be the first to share your take.
Profile
About Martin Gill
Martin Gill is Chief Scientific Officer at Libra Therapeutics. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.